The FDA released the data as the agency faces pressure from the Biden administration to authorize booster shots for the general public as early as next week.
Related posts:
There's a controversy over Charlie Munger's design for a big dorm at UCSB
Earnings results so far show companies are effectively navigating supply issues and rising costs
Markets could be challenged in the week ahead as the Fed prepares to reverse easy policy
Where to get the best rates on your emergency savings amid rising inflation